Distinguished Oncologist and Cancer Data Researcher, Dr. Amy Abernethy, Joins Flatiron Health as Chief Medical Officer and SVP of Oncology

July 3, 2014
Hire boosts Flatiron Health’s efforts to improve cancer care by revolutionizing cancer data and analytics

NEW YORK, NY

Flatiron Health is announcing the appointment of Amy Abernethy, MD, PhD, as the new chief medical officer and senior vice president of oncology. Dr. Abernethy is an internationally recognized oncologist and cancer researcher from Duke University and the co-director of both the Duke Center for Learning Health Care and the Duke Cancer Care Research Program. For more than a decade, she has pioneered the development of technology platforms to spur novel advancements in cancer care, including the development of systems by which big data can support personalized medicine and scientific discovery.

Dr. Abernethy will help direct Flatiron Health through the next phase of the company’s growth. Flatiron Health aims to improve cancer care by organizing the world’s real-world oncology data and making it useful for patients, physicians and researchers. Dr. Abernethy’s expertise will support the practical implementation of personalized cancer care by helping Flatiron Health provide the data that enables the right patient to get the right therapy at the right time.

“We are at a critical crossroads in cancer care,” said Dr. Abernethy. “Cancer data science has the potential to improve the lives of countless patients and families. But we still need to develop the strategic and operational pathways. Flatiron Health has the vision and ingenuity needed to revolutionize cancer care and I’m excited to be a member of the team working to solve this puzzle.”

“Being able to recruit one of the industry’s top cancer physicians and cancer data scientists, who is also a major proponent of patient-centered care, is a huge boost to Flatiron Health’s efforts,” said Nat Turner, Flatiron Health’s co-founder. “Dr. Abernethy’s hire, along with our recent successful funding round and acquisition of Altos Solutions, will help Flatiron Health move quickly to address the data opportunity in cancer.”

At Flatiron Health, Dr. Abernethy will collaborate with cancer care providers, life science companies and data partners to solve practical data and analytic problems. She will lead the clinical and oncology data teams, and contribute to the strategic vision of Flatiron Health. Dr. Abernethy will be on a leave of absence from the majority of her responsibilities at Duke University in order to advance this mission.

 

Location:
NEW YORK, NY, July 2, 2014

About Flatiron
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth

Media Contact: Nina Toor